Ad
related to: phenylephrine spray side effects for women
Search results
Results From The WOW.Com Content Network
The concern goes beyond ineffectiveness; phenylephrine can come with side effects such as headaches, insomnia and nervousness. ... It also found people prefer oral decongestants over nasal spray 3 ...
The FDA is not questioning the effectiveness of nasal spray phenylephrine. Parikh said that it may improve symptoms temporarily , but she advised that people use nasal spray phenylephrine only for ...
Phenylephrine has been recognized as ineffective by many in the medical community for years. In fact, the American Chemical Society recently referred to it as a “fake decongestant.”
Phenylephrine, sold under the brand names Neosynephrine and Sudafed PE among others, is a medication used as a decongestant for uncomplicated nasal congestion in the form of a nasal spray or oral tablet, [5] to dilate the pupil, to increase blood pressure given intravenously in cases of low blood pressure, and to relieve hemorrhoids as a suppository.
Pseudoephedrine acts indirectly on the adrenergic receptor system, whereas phenylephrine and oxymetazoline are direct agonists. The effects are not limited to the nose, and these medicines may cause hypertension (high blood pressure) through vasoconstriction; it is for this reason that people with hypertension are advised to avoid them. Most ...
Phenylephrine is also still thought to be effective when used as a nasal spray, said Dr. Wynne Armand, a primary care physician at Massachusetts General Hospital.
Phenylephrine is an oral medication primarily used as a decongestant. [5] [6] It is a selective α 1-adrenergic receptor activator which results in the constriction of both arteries and veins. [5] Common side effects include nausea, headache, and anxiety. [5] Phenylephrine was patented in 1927 and came into medical use in 1938. [7]
Phenylephrine is the main ingredient used in many common over-the-counter congestion products. It is safe to use, but an independent advisory committee to the FDA agreed Tuesday that it is ...